Drug recall D-1068-2019
Product
Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-3124-01
Reason for recall
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Lots and codes
Lot#: T78191, Exp.04/2019, T97494, Exp.07/2019
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 820 cartons (25 vials per carton)
- Distribution
- Nationwide USA and Guam
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2019
- Terminated
- August 11, 2022
Related products
- Cleocin Phosphate – drug information
- NDC 0009-0775 Cleocin Phosphate · Clindamycin Phosphate 150 mg/mL · Pharmacia & Upjohn Company LLC
- NDC 0009-0902 Cleocin Phosphate · Clindamycin Phosphate 150 mg/mL · Pharmacia & Upjohn Company LLC
- NDC 0009-0870 Cleocin Phosphate · Clindamycin Phosphate 150 mg/mL · Pharmacia & Upjohn Company LLC